MENU
+Compare
IQV
Stock ticker: NYSE
AS OF
Nov 13, 03:55 PM (EDT)
Price
$223.77
Change
+$2.89 (+1.31%)
Capitalization
37.62B

IQV IQVIA Holdings Forecast, Technical & Fundamental Analysis

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider... Show more

IQV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IQV with price predictions
Nov 12, 2025

IQV sees its Stochastic Oscillator ascends from oversold territory

On November 11, 2025, the Stochastic Oscillator for IQV moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 65 instances where the indicator left the oversold zone. In of the 65 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 11, 2025. You may want to consider a long position or call options on IQV as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IQV advanced for three days, in of 313 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 237 cases where IQV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for IQV moved out of overbought territory on October 27, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 similar instances where the indicator moved out of overbought territory. In of the 43 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for IQV turned negative on October 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IQV broke above its upper Bollinger Band on October 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.105) is normal, around the industry mean (12.372). P/E Ratio (30.382) is within average values for comparable stocks, (132.213). Projected Growth (PEG Ratio) (1.323) is also within normal values, averaging (1.928). IQV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (2.441) is also within normal values, averaging (9.791).

View a ticker or compare two or three
IQV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

IQV is expected to report earnings to rise 13.33% to $3.40 per share on February 18

IQVIA Holdings IQV Stock Earnings Reports
Q4'25
Est.
$3.40
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.01
The last earnings report on October 28 showed earnings per share of $3.00, beating the estimate of $2.97. With 709.87K shares outstanding, the current market capitalization sits at 37.62B.
A.I. Advisor
published General Information

General Information

a provider of biopharmaceutical development services and commercial outsourcing services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
2400 Ellis Road
Phone
+1 919 998-2000
Employees
87000
Web
https://www.iqvia.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SLX80.261.80
+2.29%
VanEck Steel ETF
HEWJ54.310.59
+1.10%
iShares Currency Hedged MSCI Japan ETF
TECL136.601.15
+0.85%
Direxion Daily Technology Bull 3X ETF
BUFP29.730.01
+0.02%
PGIM Laddered S&P 500 Buffer 12 ETF
JULJ25.12N/A
+0.01%
Innovator Premium Income 30 Bar ETF -Jul

IQV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with TMO. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+1.08%
TMO - IQV
76%
Closely correlated
+0.26%
RVTY - IQV
75%
Closely correlated
-0.19%
A - IQV
75%
Closely correlated
+1.41%
MEDP - IQV
74%
Closely correlated
-0.86%
CRL - IQV
74%
Closely correlated
-1.15%
More

Groups containing IQV

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+1.08%
IQV
(10 stocks)
89%
Closely correlated
-0.59%